Biotech · updated daily
Biotech companies hiring now
125 biotech companies are hiring right now, with 3,836 open roles on their own career pages: drug discovery, AI for biology and life-science tools. They opened 490 new roles in the last 7 days. The biggest hirers: AbbVie, Amgen, Bms.
AbbVie
North Chicago, US · Post Ipo
The company focuses on therapy areas including rheumatology, dermatology, gastroenterology, oncology, neuroscience, eye care, aesthetics, and infectious diseases.
1,336 open roles+380 this week
Amgen
Thousand Oaks, US · Post Ipo
Amgen is a biotechnology company that develops medicines and related healthcare products.
1,237 open roles+10 this week
Bms
Princeton, US · Post Ipo
Bristol Myers Squibb develops medicines and other biopharmaceutical products for healthcare markets.
318 open roleshiring
Tempus Labs
Chicago, US · Post Ipo
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. Its proprietary platform connects real-world evidence to deliver real-time, actionable insights to physicians for personalized patient care.
103 open roleshiring
Benchling
San Francisco, US · Series F
Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.
58 open roles+8 this week
Precision for Medicine
Precision for Medicine is a biomarker-driven clinical research and development services organization for life sciences companies. Its approach integrates clinical trial design and execution with scientific knowledge, laboratory expertise and data intelligence. It runs a CRO with oncology and rare disease expertise. It also offers translational and biomarker laboratory services with global clinical logistics.
47 open roles+15 this week
Twist Bioscience
South San Francisco, US · Post Ipo
The company developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high-throughput silicon platform.
43 open roles+7 this week
Oxford Nanopore
Oxford Nanopore provides devices for DNA and RNA sequencing. Its MinKNOW software records sequencing signals and controls the devices.
37 open roles+3 this week
Schrödinger
New York, US
Schrödinger offers a computational platform for discovering novel, optimized molecules for drug development and materials design. The platform uses the physics of molecular interactions, accelerated by machine learning, to simulate and predict properties of novel molecules. Its software is licensed by biotechnology, pharmaceutical and industrial companies and academic institutions.
35 open roles+1 this week
Alamar Biosciences
Alamar Biosciences provides a platform to detect biomarkers with ultra-high sensitivity. The platform helps researchers examine protein biomarkers across disease states.
26 open roles+2 this week
Arc Institute
Palo Alto, US
Arc Institute conducts biological research and develops tools for scientists. Its cellular datasets support work on disease biology and computational models.
21 open roles+1 this week
Formation Bio
New York, US · Series D
Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them faster using a proprietary tech-driven platform. The company is building an AI-native platform that integrates biomedical data to guide asset selection, accelerate development, and optimize clinical trial execution.
19 open roleshiring
Vaxcyte
Vaxcyte uses its licensed cell-free protein synthesis platform to make vaccines.
18 open roles+2 this week
PacBio
Menlo Park, US · Post Ipo
PacBio develops and manufactures DNA sequencing systems for scientists and clinical researchers. Its long-read sequencing technology helps them study complex genetic questions.
17 open roleshiring
Beam Therapeutics
Beam Therapeutics develops precision genetic medicines through base editing. Its base editing technology is designed to make single base changes without double-stranded DNA breaks.
17 open roles+2 this week
Generate Biomedicines
Somerville, US · Post Ipo
Generate Biomedicines is a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform. The Generate Platform can create medicines on demand across multiple therapeutic modalities with unprecedented speed and success rates.
16 open roles+2 this week
Nautilus Biotechnology
Seattle, US · Post Ipo
Nautilus Biotechnology develops a single-molecule proteome analysis platform that uses Iterative Mapping to generate digital counts of proteins and proteoforms in biological samples. The company offers an integrated system of instruments, reagents, and software designed for broad proteome coverage and reproducible quantitative data to support drug development, biomarker discovery, and exploratory biological studies.
16 open roles+1 this week
Ginkgo Bioworks
Boston, US · Post Ipo
Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. The company provides autonomous labs that replace manual benchwork, letting scientists order experimental work from robots.
15 open roleshiring
Dyne Therapeutics
Dyne Therapeutics develops therapeutics that target muscle and the central nervous system.
13 open roleshiring
REGENXBIO
Rockville, US
REGENXBIO advances one-time treatments. Its pipeline targets rare and retinal diseases.
13 open roles+2 this week
Stoke Therapeutics
Stoke develops RNA medicines to restore protein expression. TANGO is its proprietary research platform.
12 open roles+3 this week
Radical Numerics
San Francisco, US · Seed
Radical Numerics is an AI research lab building general biological intelligence. Its team created Evo and Evo 2, generative genomics models used to create real gene-editing tools and the first whole genomes designed entirely by AI.
12 open roles+1 this week
Insitro
South San Francisco, US · Series C
Insitro is a drug discovery and development company using machine learning and data at scale to decode biology for transformative medicines. Its platform generates multi-modal cellular data and high-content phenotypic human cohort data to develop ML-driven predictive disease models.
12 open roles+1 this week
Illumina, Inc.
San Diego, US · Post Ipo
Illumina sells sequencing and array technologies for life-science research, genomics, and molecular diagnostics.
12 open roles+1 this week
Recursion
Salt Lake City, US · Post Ipo
Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system.
11 open roles+1 this week
Owkin
Paris, FR
Owkin is an agentic AI company that builds K Pro, an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology and accelerate research.
11 open roles+1 this week
Karius
Redwood City, US
Karius is a life science, venture-backed clinical metagenomics company focused on elevating patient care through microbial insights. The company's test detects microbial cell-free DNA circulating in the body to assist physicians in making rapid treatment decisions for infectious diseases.
11 open roles+2 this week
Ultima Genomics
Newark, US · Series A
Ultima Genomics is a developer of a low-cost sequencing platform.
11 open roles+4 this week
4D Molecular Therapeutics
Emeryville, US · Post Ipo
4D Molecular Therapeutics is a late-stage biotechnology company advancing durable and disease-targeted therapeutics. Its lead product candidate 4D-150 is designed to treat blinding retinal vascular diseases with a single intravitreal injection. Its second product candidate 4D-710 is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.
10 open roles+3 this week
AbCellera
AbCellera discovers and develops antibody-based medicines. Its T-cell engager platform develops multispecific antibodies for difficult-to-treat cancers.
9 open roles+1 this week
Lexeo Therapeutics
Lexeo Therapeutics develops treatments for cardiovascular diseases. Its strategy focuses on therapeutic candidates for cardiovascular and neurological diseases.
9 open roles+2 this week
CRISPR Therapeutics
Zug, CH · Post Ipo
The company achieved a historic milestone with the approval of CASGEVY (exagamglogene autotemcel), the world's first CRISPR-based therapy, for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics is advancing a broad pipeline across hemoglobinopathies, oncology, cardiovascular, autoimmune, regenerative medicine, and rare diseases.
8 open roleshiring
Relay Therapeutics
Cambridge, US · Post Ipo
Precision breast cancer therapies
8 open roles+1 this week
Latent Labs
London, GB · Series A
Latent Labs builds AI foundation models to make biology programmable. It enables biotech and pharmaceutical companies to generate and optimize proteins.
8 open roleshiring
Asimov
Boston, US · Series B
Asimov develops a mammalian synthetic biology platform to design and manufacture next-generation therapeutics.
7 open roleshiring
Ansa Biotechnologies
Emeryville, US · Series B
The company offers complex DNA synthesis products including clonal DNA up to 50 kb and linear double-stranded DNA fragments.
7 open roles+1 this week
Kriya Therapeutics
Series D
Kriya Therapeutics develops gene therapies. Its therapies target common chronic diseases.
7 open roleshiring
Orca Bio
Menlo Park, US · Series F
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. Its manufacturing platform uses single-cell precision to create personalized cell therapy products intended to replace a patient's diseased blood and immune system with a healthy one.
7 open roleshiring
Sail Biomedicines
Sail Biomedicines develops RNA medicines that instruct therapeutic activity inside selected cells.
7 open roleshiring
Octant Bio
Octant Bio develops small molecules to treat protein misfolding and mistrafficking diseases.
6 open roles+1 this week
Enveda Biosciences
Boulder, US · Series D
The Company builds a large library of plant-derived molecules and uses AI to discover novel small molecule therapeutics from natural sources. Enveda Biosciences, Inc. develops biotechnology solutions for pharmaceutical drug discovery.
6 open roles+1 this week
GenBio AI
GenBio AI develops AI models to simulate biological systems. Its models support drug discovery and biomedical research.
6 open roleshiring
Pandorum Technologies
Series B
Pandorum Technologies develops functional human tissues for medical research and therapeutic applications. It develops cell-free treatments for tissue damage caused by inflammation and fibrosis.
6 open roleshiring
Gordian Biotechnology
Gordian Biotechnology starts drug discovery in animals that represent human patients.
6 open roles+1 this week
Superluminal Medicines
Series B
Superluminal Medicines integrates structural biology with proprietary machine learning tools.
6 open roleshiring
Personalis
Fremont, US · Post Ipo
Personalis provides genomic sequencing and analytics solutions for developing vaccines to treat cancers. The company develops end-to-end solutions for immuno-oncology through its Immunoid NeXT Platform.
5 open roles+1 this week
ProQR Therapeutics
ProQR Therapeutics develops RNA therapies. Its scientists invented a way to alter RNA with RNA oligonucleotides.
5 open roleshiring
Strand Therapeutics
Boston, US · Series B
Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics. Its proprietary Signal Stack platform integrates EverScript circular RNA, AmpliScript self-replicating RNA, SignalPath targeted delivery, and logic-driven SignalLock genetic circuits. The company is advancing a pipeline with an initial focus on oncology and autoimmune disease.
5 open roles+3 this week
Tropic
Series C
Tropic uses CRISPR gene editing to improve delayed ripening in bananas.
5 open roleshiring
Retro Biosciences
Redwood City, US
Retro Biosciences develops therapies that meaningfully reverse age-related diseases. The company focuses on cellular reprogramming and autophagy to rejuvenate cell and tissue function.
5 open roleshiring
Umoja Biopharma
Series C
Umoja Biopharma develops in vivo CAR T cell therapies. Its VivoVec platform generates CAR T cells directly inside the patient.
5 open roles+1 this week
Pivot Bio
Berkeley, US · Series D
Pivot Bio is a sustainable agriculture company delivering farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow food. Its proprietary ON Technology harnesses naturally occurring microbes to provide more nutrients to crops, enabling microbes to fix and supply more nitrogen to corn.
5 open roles+1 this week
MeiraGTx
MeiraGTx develops viral vectors using capsids, promoters and translational control elements. Its pipeline has end-to-end in-house manufacturing.
5 open roleshiring
Prime Medicine
Cambridge, US · Post Ipo
Prime Medicine is a biotechnology company that uses Prime Editing, a next-generation gene editing technology, to develop one-time curative genetic therapies.
5 open roles+1 this week
Krystal Biotech
Pittsburgh, US
Krystal Biotech develops genetic medicines for patients with rare diseases. Its pipeline uses its proprietary redosable HSV vector.
5 open roleshiring
Terray Therapeutics
Monrovia, US · Series B
Terray Therapeutics is a biotechnology company that integrates ultra-high throughput experimentation and generative AI to discover and develop small molecule therapeutics. Its platform, tNova, combines experimentation and computation to improve the speed, cost, and success rate of small molecule drug discovery.
5 open roles+2 this week
A-Alpha Bio
A-Alpha Bio measures protein-protein binding affinities with AlphaSeq. Its AlphaBind platform predicts binding strength from protein sequence.
5 open roleshiring
Kyverna Therapeutics
Emeryville, US · Post Ipo
Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell therapy for conditions such as stiff person syndrome and myasthenia gravis.
5 open roleshiring
ElevateBio
Waltham, US · Series D
ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization.
4 open roleshiring
Glyphic Biotechnologies
Series A
Glyphic Biotechnologies, Inc. is developing the first truly de novo high-throughput proteome sequencing technology capable of discriminating all 20 AAs and PTMs accurately with single molecule sensitivity.
4 open roleshiring
landed applies. You interview.
Let landed apply to biotech companies for you
landed applies to jobs like these on each company’s own site, with answers written for the role. 10 free auto-applies, no card.
Frequently asked
Which biotech companies are hiring right now?
125 biotech companies have open roles. The most: AbbVie (1,336), Amgen (1,237), Bms (318), Tempus Labs (103), Benchling (58).
What roles do biotech companies hire for?
Mostly sales & business development, research & science, software engineering.
Where are biotech companies based?
The biggest hubs are San Francisco, Cambridge, South San Francisco, Boston.